Crossmark

Rapamycin golden jubilee and still the miraculous drug: a potent immunosuppressant, antitumor, rejuvenative agent, and potential contributor in COVID-19 treatment

Crossref DOI link: https://doi.org/10.1186/s40643-022-00554-y

Published Online: 2022-06-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohamed, Mohamed A.

Elkhateeb, Waill A.

Daba, Ghoson M. http://orcid.org/0000-0002-0908-6811
Funding

Funding for this research was provided by:

National Research Centre (12010122)

National Research Centre Egypt
License Information

Text and Data Mining valid from 2022-06-13

Version of Record valid from 2022-06-13
More Information

Article History

Received: 25 February 2022

Accepted: 27 May 2022

First Online: 13 June 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below